Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01974232
What this trial is testing

A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 33
Testing effectiveness (Phase 2)Study completedNCT01880047
What this trial is testing

Safety and Efficacy of Eltrombopag at Escalated Doses

Who this might be right for
Immune ThrombocytopeniaPlatelet Disorder
Weill Medical College of Cornell University 35
Not applicableUnknownNCT03183284
What this trial is testing

Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic Purpra

Who this might be right for
Immune Thrombocytopenia
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT02338414
What this trial is testing

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Samsung Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT02401061
What this trial is testing

PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT03102593
What this trial is testing

Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
argenx 38
Not applicableUnknownNCT04311593
What this trial is testing

Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenia
Assiut University 68
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableUnknownNCT04735588
What this trial is testing

Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP

Who this might be right for
Immune ThrombocytopeniaITPCovid19+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 140
Not applicableEnded earlyNCT01386723
What this trial is testing

End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 35
Not applicableUnknownNCT04214951
What this trial is testing

Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 100
Large-scale testing (Phase 3)UnknownNCT03692754
What this trial is testing

Atorvastatin in Management of Newly Diagnosed ITP

Who this might be right for
Immune ThrombocytopeniaPurpura, Thrombocytopenic
Shandong University 30
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Post-approval studies (Phase 4)UnknownNCT05520892
What this trial is testing

Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children

Who this might be right for
Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment
Fujian Medical University Union Hospital 580
Early research (Phase 1)Looking for participantsNCT06880081
What this trial is testing

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Chongqing Peg-Bio Biopharm Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT05995054
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 110
Testing effectiveness (Phase 2)UnknownNCT04588194
What this trial is testing

Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaThrombotic Thrombocytopenic Purpura
David Gomez Almaguer 12
Testing effectiveness (Phase 2)Study completedNCT04812483
What this trial is testing

Immunomodulation With Eltrombopag in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
University Children's Hospital Basel 2
Not applicableWithdrawnNCT01317966
What this trial is testing

Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Ming Hou
Testing effectiveness (Phase 2)Study completedNCT03395210
What this trial is testing

Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 86
Next Page